medline.ch Gastroenterologie Pankreas Neoplasie

	IS THERE A ROLE FOR BILIODIGESTIVE BYPASS SURGERY IN TREATING CHOLESTASIS IN ADVANCED PANCREATIC CANCER? Arq Bras Cir Dig Stolzemburg LCP, Tustumi F, Ribeiro TC, Jureidini R, Sorbello MP, Maluf-Filho F, Jukemura J, Ribeiro Junior U, Namur GN. PMID: 39292098 [PubMed - indexed for MEDLINE]
	Total versus Partial Pancreatectomy in Patients with Pancreatic Cancer Arising from Multifocal or Diffuse Intraductal Papillary Mucinous Neoplasia - A Multicenter Observational Study. Ann Surg Rompen IF, Habib JR, Kinny-Köster B, Campbell BA, Stoop TF, Kümmerli C, Andel PCM, Leseman CA, Lesch C, Daamen LA, Javed AA, Lafaro KJ, Nienhüser H, Billeter AT, Molenaar IQ, Müller-Stich BP, Besselink MG, He J, Loos M, Büchler MW, Wolfgang CL. PMID: 39291382 [PubMed - as supplied by publisher]
	MicroRNAs: emerging biomarkers and therapeutic targets in pancreatic cancer. Front Mol Biosci Yuan J, Yan K, Guo Y, Li Y. PMID: 39290995 [PubMed]
	Impact of ACEI/ARB use on the survival of hypertensive patients with cancer: A metaâ€‘analysis. Oncol Lett Xiao Y, Chen X, Li W, Li X, Zhou W. PMID: 39290956 [PubMed]
	Effect of postsurgical adjuvant chemotherapy timing on outcomes in patients with pancreatic cancer - a systematic review and meta-analysis. J Chemother Zhou L, Zhang L. PMID: 39289876 [PubMed - as supplied by publisher]
	Molecular diagnosis for detecting KRAS mutation in peritoneal washing fluid of pancreatic ductal adenocarcinoma. Sci Rep Shimane G, Nakano Y, Matsuda S, Kitago M, Masugi Y, Nakamura K, Nakamura Y, Yagi H, Abe Y, Hasegawa Y, Hori S, Tanaka M, Takemura R, Nishihara H, Kitagawa Y. PMID: 39289461 [PubMed - indexed for MEDLINE]
	CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study. J Gastroenterol Ueno M, Takeda H, Takai A, Morimura H, Nishijima N, Iwamoto S, Okuyama S, Umeda M, Seta T, Ikeda A, Goto T, Miyamoto S, Kayahara T, Uenoyama Y, Matsumura K, Nakano S, Mishima M, Inuzuka T, Eso Y, Takahashi K, Marusawa H, Osaki Y, Hatano E, Seno H. PMID: 39289234 [PubMed - as supplied by publisher]
	Nanoquercetin based nanoformulations for triple negative breast cancer therapy and its role in overcoming drug resistance. Discov Oncol Samantaray A, Pradhan D, Nayak NR, Chawla S, Behera B, Mohanty L, Bisoyi SK, Gandhi S. PMID: 39287822 [PubMed]
	The value of splenectomy during left-sided pancreatectomy for pancreatic ductal adenocarcinoma: predefined subanalysis in the DIPLOMA randomized trial. Br J Surg Bruna CL, van Hilst J, Esposito A, Kleive D, Falconi M, Primrose JN, Korrel M, Bianchi D, Zerbi A, Kokkola A, Butturini G, Björnsson B, Morone M, Casadei R, Marudanayagam R, Besselink MG, Abu Hilal M, European Consortium on Minimally Invasive Pancreatic Surgery (E-MIPS). PMID: 39287489 [PubMed - indexed for MEDLINE]
	Predictive potential of dynamic contrast-enhanced MRI and plasma-derived angiogenic factors for response to concurrent chemoradiotherapy in human papillomavirus-negative oropharyngeal cancer. Radiol Oncol Longo A, Hudler P, Strojan P, Plavc G, Umek L, Popovic KS. PMID: 39287165 [PubMed - indexed for MEDLINE]
	Ponsegromab for the Treatment of Cancer Cachexia. N Engl J Med Groarke JD, Crawford J, Collins SM, Lubaczewski S, Roeland EJ, Naito T, Hendifar AE, Fallon M, Takayama K, Asmis T, Dunne RF, Karahanoglu I, Northcott CA, Harrington MA, Rossulek M, Qiu R, Saxena AR. PMID: 39282907 [PubMed - as supplied by publisher]
	Application of Survival Quilts for prognosis prediction of gastrectomy patients based on the Surveillance, Epidemiology, and End Results database and China National Cancer Center Gastric Cancer database. J Natl Cancer Cent Zhao L, Niu P, Wang W, Han X, Luan X, Huang H, Zhang Y, Zhao D, Gao J, Chen Y. PMID: 39282580 [PubMed]
	Serum PCSK9 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer. PeerJ Xu Y, Xu Y, Yang Y, Zhang Z, Xiong Q, Zhu Q. PMID: 39282119 [PubMed - indexed for MEDLINE]
	Cancer survival statistics in China 2019-2021: a multicenter, population-based study. J Natl Cancer Cent Zeng H, Zheng R, Sun K, Zhou M, Wang S, Li L, Chen R, Han B, Liu M, Zhou J, Xu M, Wang L, Yin P, Wang B, You J, Wu J, Wei W, He J. PMID: 39281724 [PubMed]
	Particle therapy in gastrointestinal cancer-a narrative review. J Gastrointest Oncol Mattke M. PMID: 39279975 [PubMed]
	Fruquintinib in metastatic colorectal cancer: a multicenter real-world analysis on efficacy, safety, and predictive and prognostic factors. J Gastrointest Oncol Wang Y, Xu J, Dong M, Liu K, Lu Y, Chen K, Cao Y, Shi H, Bei Y, Li J, Zhao J, Cao Y, Lu N, Yang L, Liu H, Cai P, Li K, Yang T, He N, Dong J, Zhang C. PMID: 39279967 [PubMed]
	Liquid-liquid phase separation-related features of PYGB/ACTR3/CCNA2/ITGB1/ATP8A1/RAP1GAP2 predict the prognosis of pancreatic cancer. J Gastrointest Oncol Li X, Yu R, Shi B, Chawla A, Feng X, Zhang K, Liang L. PMID: 39279964 [PubMed]
	Cancer-Associated Fibroblasts: From Spectators to Protagonists in Pancreatic Cancer Progression. Cancer Res Mucciolo G, Li W, Biffi G. PMID: 39279382 [PubMed - indexed for MEDLINE]
	Nutrient Levels and Nutrient Sources in Pancreatic Tumors. Cancer Res Groessl S, Palm W. PMID: 39279381 [PubMed - indexed for MEDLINE]
	Hope on the Horizon: A Revolution in KRAS Inhibition Is Creating a New Treatment Paradigm for Patients with Pancreatic Cancer. Cancer Res Aguirre AJ, Stanger BZ, Maitra A. PMID: 39279379 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 53260

Seite 1 von 2663

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung